Recently active

Unread page 6

On the live site this tab tracks what you have not read. In this static rendering it shows every topic with activity in the last 45 days, which is the closest honest equivalent — we would rather explain the difference than pretend a static page knows your reading history.

414 topics · page 6 of 14

Topic	Participants	Replies	Views	Activity
A community side-effect dataset, with its response rate and biases Data & Tools › Datasets confounding site feedback data table observational data Solved A community side-effect dataset, with its response rate and biases — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies…		2	5.1k	19h
Why retatrutide discussion here is more cautious than elsewhere — one year on Compounds › Retatrutide TRIUMPH programme effect size preprint retatrutide Asking directly, because I could not find a straight answer: Why retatrutide discussion here is more cautious than elsewhere — one year on Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it…	+92	97	3.6k	20h
Lean mass preservation: what the evidence supports — does this still hold? Outcomes › Body composition bioimpedance lean mass loss data table DXA Asking directly, because I could not find a straight answer: Lean mass preservation: what the evidence supports — does this still hold? Maintenance rather than loss, which is the part of this that almost…	+112	122	5.2k	20h
Shakes versus food: a pragmatic assessment Nutrition & Training › Protein & intake lean mass loss micronutrients constipation Shakes versus food: a pragmatic assessment Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this that almost nobody writes…	+22	26	53k	20h
Tracking intake honestly when appetite is absent Nutrition & Training › Protein & intake constipation fatigue micronutrients lean mass loss Solved On the subject in the title: Tracking intake honestly when appetite is absent Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…	+109	115	4.8k	20h
Solubility limits and what a cloudy solution is telling you Pharmacology › Formulation chemistry cloudy or discoloured solution storage counter-ion content Solubility limits and what a cloudy solution is telling you — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate…	+11	15	34k	20h
Review: a draft on reconstitution arithmetic, with objections — one year on Documentation › Doc review maintainership citation check promoted to docs review date Review: a draft on reconstitution arithmetic, with objections — one year on Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…	+46	51	11k	20h
Publication patterns in the BPC-157 literature, examined Compounds › Repair & healing peptides preprint BPC-157 TB-500 needs a source Solved Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in support of…	+40	45	3.4k	21h
A site rotation scheme that is easy enough to actually follow Practice › Administration needle gauge & length missed dose injection site rotation aseptic technique On the subject in the title: A site rotation scheme that is easy enough to actually follow Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly…	+112	125	5.8k	21h
Revisiting: Spike-and-recover accuracy for a peptide assay Analytics › Method validation LOD & LOQ system suitability stability-indicating method linearity Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere.…		2	6.8k	21h
What I would want from a home test that does not exist yet — what changed since Analytics › Home & field testing third-party testing LOD & LOQ documentation quality ELISA Solved Asking directly, because I could not find a straight answer: What I would want from a home test that does not exist yet — what changed since Posting the method first, because I know what the first three…	+101	111	1.9k	21h
Journal club: the CagriSema phase 2 combination paper Evidence › Journal club randomised trial estimand effect size On the subject in the title: Journal club: the CagriSema phase 2 combination paper Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a claim I do not…		2	329	21h
Submitting a sample: the process end to end Sourcing › Independent verification blind sampling PeptideMeter VendorInvestigate third-party testing On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product quality.…	+99	114	29k	21h
Coming back to: When a red flag was a misunderstanding, and the retraction Sourcing › Red flags mislabelling moderation documentation quality When a red flag was a misunderstanding, and the retraction I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the answers here are usually…	+6	10	257	21h
Prior authorisation: what the criteria usually require — a second dataset Access › Insurance & coverage prior authorisation insurance formulary appeals Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. A coverage question with the paperwork detail…	+67	74	19k	21h
Prescription portability between countries — the long version Access › International EMA NHS telehealth On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…		2	182	21h
[2026 update] Waist circumference technique and its repeatability Outcomes › Progress reports DXA long read effect size data table Posting this under the heading it deserves: Waist circumference technique and its repeatability Everything below is what sits behind that. Longitudinal report with the method stated, because a number without…	+23	27	5.9k	21h
Retatrutide mass and identity: what a report should show Compounds › Retatrutide TRIUMPH programme preprint retatrutide effect size Solved Posting this under the heading it deserves: Retatrutide mass and identity: what a report should show Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with STEP 4 ( JAMA , 2021)…	+22	27	872	22h
Why cagrilintide alone is discussed so much less than in combination — does this still hold? Compounds › Cagrilintide & amylin analogues cagrisema randomised trial cagrilintide effect size Solved Under review Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SURMOUNT-4…	+27	31	1.2k	22h
CJC-1295 with and without DAC: what the modification does Compounds › Secretagogues & GH axis needs a source tesamorelin CJC-1295 GHRP class On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with SURMOUNT-OSA ( N Engl J Med ,…	+117	123	5.6k	22h
Second pass at: Cost versus information: making the trade-off explicitly Analytics › Home & field testing third-party testing documentation quality ELISA Posting this under the heading it deserves: Second pass at: Cost versus information: making the trade-off explicitly Everything below is what sits behind that. Working through the identity arithmetic and I…	+23	27	6.1k	22h
Immortal time bias in a claims-database study — one year on Evidence › Study critique effect size risk of bias confounding Solved Posting this under the heading it deserves: Immortal time bias in a claims-database study — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SURMOUNT-1 (…	+41	46	3.7k	22h
What a good consultation looks like from the other side Clinical › Prescriber conversations prior authorisation telehealth type 2 diabetes beginner friendly What a good consultation looks like from the other side — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about a population rather than about a person. The…	+57	62	4.9k	22h
GLP-1 receptor distribution: central and peripheral Pharmacology › Receptor biology semaglutide amylin analogues retatrutide long read Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. A documentation question rather than an analytical one. I have a…	+90	98	30k	22h
Review: a draft on reconstitution arithmetic, with objections — what changed since Documentation › Doc review promoted to docs wiki post review date citation check Posting this under the heading it deserves: Review: a draft on reconstitution arithmetic, with objections — what changed since Everything below is what sits behind that. Nominating something for promotion…	+39	50	26k	22h
Blinding yourself: practical methods and their limits — the long version Research Methods › N-of-1 designs worked example effect size confounding data table Blinding yourself: practical methods and their limits — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024)…	+7	11	1.8k	22h
About the Independent verification category Sourcing › Independent verification Janoshik Analytical Medutest PeptideMeter Pinned Wiki Janoshik, Medutest, PeptideMeter and VendorInvestigate results, how to submit a sample, and how to read what comes back. This post is a community wiki: any member at trust level 3 or above can edit it, and…	+1	5	5.8k	23h
What would change my mind about repair peptides: a specific answer Compounds › Repair & healing peptides TB-500 needs a source preprint Under review What would change my mind about repair peptides: a specific answer — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SURMOUNT-4 ( JAMA , 2024). Please…	+26	30	1.1k	23h
Journal club: what we got wrong in an earlier session Evidence › Journal club number needed to treat effect size randomised trial journal club On the subject in the title: Journal club: what we got wrong in an earlier session Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before posting; the…	+114	125	2.5k	23h
Risk-of-bias tools and the judgement they conceal — does this still hold? Evidence › Meta-analyses heterogeneity risk of bias effect size publication bias Solved Risk-of-bias tools and the judgement they conceal — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…	+26	30	5.8k	23h